A Dissonance-Based Obesity Intervention
Enhanced Project Health: A Dissonance-Based Intervention for Obesity in Young Adults
Przegląd badań
Szczegółowy opis
Approximately 34% of college students are overweight/obese. However, few behavioral weight loss (BWL) interventions have been developed for young adults in college. Research suggests that standard BWL interventions are not addressing the needs of young adults as they have shown poorer retention rates and weight loss compared to older adults in BWL trials. Standard BWL interventions are also time-intensive and are not conducive to inexpensive dissemination.
The primary aim of this project is to examine the feasibility and acceptability of Enhanced Project Health, a dissonance-based obesity intervention for young adults enrolled in college. Enhanced Project Health is based on Project Health, a dissonance-based obesity prevention program, which has been shown to significantly decrease weight gain and future overweight/obesity onset compared to a matched intervention and minimal intervention control condition in young adults. The current intervention was expanded to consist of eight weekly group sessions and to address sleep, in addition to diet and physical activity. The secondary aim is to test the hypothesis that Enhanced Project Health will result in significantly greater reductions in weight and improvements in lifestyle behaviors compared to an assessment only condition.
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Illinois
-
Chicago, Illinois, Stany Zjednoczone, 606012
- Neuropsychiatric Institute, University of Illinoist at Chicago
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- Young adults of ages 18 to 25.
- Enrolled as a college student.
- Body mass index of 25 or more (overweight/obese) based on measured height and weight.
Exclusion Criteria:
- Diagnosis of bulimia nervosa according to DSM-5 criteria.
- Diagnosis of obstructive sleep apnea.
- Participation in interventions for weight loss or disordered eating behaviors.
- Current use of prescription drugs for weight loss or disordered eating behaviors.
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Pojedynczy
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Eksperymentalny: Dissonance-based obesity intervention
Participants in this arm will receive Enhanced Project Health.
|
A dissonance-based obesity intervention consisting of eight weekly groups sessions (1.5 hours).
|
|
Brak interwencji: Assessment Only
Participants in this arm will only complete the baseline assessment and 2 month assessment.
They will not receive Enhanced Project Health.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Percentage of eligible young adults that agree to participate in the study
Ramy czasowe: Up to 1 month
|
This will be defined as a percentage of young adults that agree to participate in study out of the young adults screened for the study.
|
Up to 1 month
|
|
Time for recruitment
Ramy czasowe: Up to 1 month
|
This will be defined as time (weeks and days) from initial contact with research staff to randomization into the study.
|
Up to 1 month
|
|
Attendance rate of participants
Ramy czasowe: Assessed at 2 months
|
This will be defined as the percentage of participants attending 75% of the group sessions.
|
Assessed at 2 months
|
|
Retention rate of participants
Ramy czasowe: Assessed at 2 months
|
This will be defined as the percentage of participants remaining in the study at the post-intervention assessment.
|
Assessed at 2 months
|
|
Program Evaluation Questionnaire - Each Group Session
Ramy czasowe: Assessed from week 1 to week 8
|
This questionnaire was developed for this study. It will assess the acceptability of the intervention and will be administered at the end of each group session. Participants will be asked to rate the usefulness of the session on one item with a scale ranging from 1 to 5. Total scores range from 1 to 5. Higher scores indicate more usefulness. Participants will also be asked to respond to open-ended questions about each group session. These questions will assess the most favorable aspects, least favorable aspects, and areas of improvements. Responses will be coded using a variation of the long table approach emphasizing frequency, specificity, emotion, and extensiveness. Codes will be examined to identify themes. |
Assessed from week 1 to week 8
|
|
Program Evaluation Questionnaire - Overall Program
Ramy czasowe: Assessed at week 8
|
This questionnaire was developed for this study.
It will assess the program with regard to effectiveness and satisfaction as well as characteristics of the group leaders (clarity, knowledge, experience, respect) using a scale ranging from 1 to 5. Total scores range from 8 to 40.
Higher scores indicate more favorable responses.
This questionnaire will be administered at the end of the last group session.
|
Assessed at week 8
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Body Mass Index (kg/m^2)
Ramy czasowe: Baseline to 2 months
|
Body Mass Index will be calculated using measured weight and height (kg/m^2)
|
Baseline to 2 months
|
|
International Physical Activity Questionnaire-Short Form (IPAQ-S)
Ramy czasowe: Baseline to 2 months
|
The International Physical Activity Questionnaire-Short Form will assess walking, moderate-intensity activity, and vigorous-intensity activity.
The scores for each type of physical activity are converted to MET-minutes/week as defined by the following: Walking MET-minutes/week = 3.3 * walking minutes * walking days; Moderate MET-minutes/week = 4.0 * moderate-intensity activity minutes * moderate days; Vigorous MET-minutes/week = 8.0 * vigorous-intensity activity minutes * vigorous-intensity days; Total physical activity MET-minutes/week = sum of Walking + Moderate + Vigorous MET-minutes/week scores.
The total score will be computed by summing the duration (in minutes) and frequency (days) of each activity.
Higher duration and frequency indicate more engagement in physical activity.
The pattern of physical activity can also be classified as low, moderate, or high based on the total score.
|
Baseline to 2 months
|
|
Actigraph GT3XP-BTLE
Ramy czasowe: Baseline to 2 months
|
An accelerometer will record physical activity for a 1 week period
|
Baseline to 2 months
|
|
Pittsburgh Sleep Quality Index (PSQI)
Ramy czasowe: Baseline to 2 months
|
The Pittsburgh Sleep Quality Index will assess the quality and patterns of sleep using a scale ranging from 0 to 3. Total scores range from 8 to 57.
Higher scores indicate greater sleep disturbances.
|
Baseline to 2 months
|
Współpracownicy i badacze
Śledczy
- Główny śledczy: Sylvia Herbozo, Ph.D., University of Illinois at Chicago
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- 2019-0892
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .